Diffuse Alveolar Hemorrhage Associated With Anti-PL-7 Antisynthetase Syndrome: A Case Report.

Paul Shiu, Shannon Iriza, Steven Templeton
Author Information
  1. Paul Shiu: Prisma Health, University of South Carolina-School of Medicine, Columbia, South Carolina, USA. ORCID
  2. Shannon Iriza: Prisma Health, University of South Carolina-School of Medicine, Columbia, South Carolina, USA. ORCID
  3. Steven Templeton: Prisma Health, University of South Carolina-School of Medicine, Columbia, South Carolina, USA. ORCID

Abstract

Diffuse alveolar hemorrhage (DAH) is a potentially life-threatening condition which can present with hemoptysis, diffuse alveolar infiltrates, anemia, and hypoxic respiratory failure. Antisynthetase syndrome (AS) is a rare autoimmune disorder most often characterized by nonerosive arthritis, proximal muscle weakness with elevated muscle enzymes, Raynaud's phenomenon, hyperkeratosis of the digits (mechanic's hands), and interstitial lung disease. According to large population studies, AS has an annual incidence of 0.56 per 100,000 persons and prevalence of 9 per 100,000. The most common autoantibody is anti-aminoacyl-transfer RNA synthetase for histidine (anti-Jo-1) with a reported prevalence of 20%-30%, whereas anti-Pl-7 (for threonine) accounts for less than 5% of all autoimmune myositis. Specific myositis autoantibodies determine clinical phenotype. PL-7 is characterized by interstitial lung disease, myositis, and arthritis. autoimmune myositis, specifically AS, is a rare cause of DAH. Herein, we describe the first reported case of PL-7-associated AS with DAH. A 41-year-old female presented with worsening shortness of breath and hemoptysis. Laboratory studies included a hemoglobin of 10.5 g/dL, mildly elevated liver enzymes, and a creatine phosphokinase (CPK) of nearly 4000 U/L. CT of the chest showed diffuse ground glass opacities bilaterally. Serial aliquots of the bronchoalveolar lavage (BAL) fluid revealed progressively hemorrhagic return and histopathologic analysis consistent with DAH. Other concurrent causes of DAH were ruled out. Although rare, AS should be considered a cause of DAH, particularly in patients presenting with symptoms of muscle weakness and arthritis or with evidence of mechanic's hands.

References

  1. Curr Rheumatol Rep. 2019 Sep 6;21(10):56 [PMID: 31493005]
  2. Am J Respir Crit Care Med. 1995 Jun;151(6):2037-40 [PMID: 7767555]
  3. Lancet Respir Med. 2023 Jan;11(1):45-54 [PMID: 36375479]
  4. Arthritis Care Res (Hoboken). 2013 May;65(5):800-8 [PMID: 23203765]
  5. Case Rep Rheumatol. 2019 Jul 31;2019:5453717 [PMID: 31467762]
  6. Semin Arthritis Rheum. 2013 Feb;42(4):391-400 [PMID: 22985708]
  7. Scand J Rheumatol. 2018 Sep;47(5):392-399 [PMID: 29916287]
  8. J Bras Pneumol. 2011 Jan-Feb;37(1):100-9 [PMID: 21390438]
  9. Int J Rheum Dis. 2013 Apr;16(2):233-4 [PMID: 23773650]
  10. An Bras Dermatol. 2016 Sep-Oct;91(5):683-685 [PMID: 27828653]
  11. Postgrad Med J. 2013 May;89(1051):274-83 [PMID: 23349383]
  12. Autoimmunity. 2006 May;39(3):249-53 [PMID: 16769659]
  13. Respir Med Case Rep. 2020 Oct 17;31:101261 [PMID: 33145158]
  14. Tuberc Respir Dis (Seoul). 2013 Apr;74(4):151-62 [PMID: 23678356]
  15. Ann Rheum Dis. 2017 Nov;76(11):1803-1808 [PMID: 28855175]
  16. Arthritis Care Res (Hoboken). 2024 Aug;76(8):1051-1069 [PMID: 38973731]

Word Cloud

Created with Highcharts 10.0.0DAHASmyositisrarearthritismuscleDiffusealveolarhemoptysisdiffuseAntisynthetaseautoimmunecharacterizedweaknesselevatedenzymesmechanic'shandsinterstitiallungdiseasestudiesper100000prevalencereportedcausehemorrhagepotentiallylife-threateningconditioncanpresentinfiltratesanemiahypoxicrespiratoryfailuresyndromedisorderoftennonerosiveproximalRaynaud'sphenomenonhyperkeratosisdigitsAccordinglargepopulationannualincidence056persons9commonautoantibodyanti-aminoacyl-transferRNAsynthetasehistidineanti-Jo-120%-30%whereasanti-Pl-7threonineaccountsless5%SpecificautoantibodiesdetermineclinicalphenotypePL-7AutoimmunespecificallyHereindescribefirstcasePL-7-associated41-year-oldfemalepresentedworseningshortnessbreathLaboratoryincludedhemoglobin105 g/dLmildlylivercreatinephosphokinaseCPKnearly4000 U/LCTchestshowedgroundglassopacitiesbilaterallySerialaliquotsbronchoalveolarlavageBALfluidrevealedprogressivelyhemorrhagicreturnhistopathologicanalysisconsistentconcurrentcausesruledAlthoughconsideredparticularlypatientspresentingsymptomsevidenceAlveolarHemorrhageAssociatedAnti-PL-7Syndrome:CaseReport

Similar Articles

Cited By

No available data.